These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary Binding. Longo NS; Sutton MS; Shiakolas AR; Guenaga J; Jarosinski MC; Georgiev IS; McKee K; Bailer RT; Louder MK; O'Dell S; Connors M; Wyatt RT; Mascola JR; Doria-Rose NA J Virol; 2016 Dec; 90(23):10574-10586. PubMed ID: 27654288 [TBL] [Abstract][Full Text] [Related]
3. Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies. Ingale J; Tran K; Kong L; Dey B; McKee K; Schief W; Kwong PD; Mascola JR; Wyatt RT J Virol; 2014 Dec; 88(24):14002-16. PubMed ID: 25253346 [TBL] [Abstract][Full Text] [Related]
4. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency. Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728 [TBL] [Abstract][Full Text] [Related]
5. Structural Constraints at the Trimer Apex Stabilize the HIV-1 Envelope in a Closed, Antibody-Protected Conformation. Guzzo C; Zhang P; Liu Q; Kwon AL; Uddin F; Wells AI; Schmeisser H; Cimbro R; Huang J; Doria-Rose N; Schmidt SD; Dolan MA; Connors M; Mascola JR; Lusso P mBio; 2018 Dec; 9(6):. PubMed ID: 30538178 [TBL] [Abstract][Full Text] [Related]
6. Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization. Kim AS; Leaman DP; Zwick MB PLoS Pathog; 2014 Jul; 10(7):e1004271. PubMed ID: 25058619 [TBL] [Abstract][Full Text] [Related]
7. Global Increases in Human Immunodeficiency Virus Neutralization Sensitivity Due to Alterations in the Membrane-Proximal External Region of the Envelope Glycoprotein Can Be Minimized by Distant State 1-Stabilizing Changes. Wang Q; Esnault F; Zhao M; Chiu TJ; Smith AB; Nguyen HT; Sodroski JG J Virol; 2022 Apr; 96(7):e0187821. PubMed ID: 35289647 [TBL] [Abstract][Full Text] [Related]
8. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Kong L; Lee JH; Doores KJ; Murin CD; Julien JP; McBride R; Liu Y; Marozsan A; Cupo A; Klasse PJ; Hoffenberg S; Caulfield M; King CR; Hua Y; Le KM; Khayat R; Deller MC; Clayton T; Tien H; Feizi T; Sanders RW; Paulson JC; Moore JP; Stanfield RL; Burton DR; Ward AB; Wilson IA Nat Struct Mol Biol; 2013 Jul; 20(7):796-803. PubMed ID: 23708606 [TBL] [Abstract][Full Text] [Related]
9. HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies. Chakrabarti BK; Pancera M; Phogat S; O'Dell S; McKee K; Guenaga J; Robinson J; Mascola J; Wyatt RT AIDS Res Hum Retroviruses; 2011 Aug; 27(8):877-87. PubMed ID: 21158699 [TBL] [Abstract][Full Text] [Related]
10. Visualization of retroviral envelope spikes in complex with the V3 loop antibody 447-52D on intact viruses by cryo-electron tomography. Dutta M; Liu J; Roux KH; Taylor KA J Virol; 2014 Nov; 88(21):12265-75. PubMed ID: 25122783 [TBL] [Abstract][Full Text] [Related]
11. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. McLellan JS; Pancera M; Carrico C; Gorman J; Julien JP; Khayat R; Louder R; Pejchal R; Sastry M; Dai K; O'Dell S; Patel N; Shahzad-ul-Hussan S; Yang Y; Zhang B; Zhou T; Zhu J; Boyington JC; Chuang GY; Diwanji D; Georgiev I; Kwon YD; Lee D; Louder MK; Moquin S; Schmidt SD; Yang ZY; Bonsignori M; Crump JA; Kapiga SH; Sam NE; Haynes BF; Burton DR; Koff WC; Walker LM; Phogat S; Wyatt R; Orwenyo J; Wang LX; Arthos J; Bewley CA; Mascola JR; Nabel GJ; Schief WR; Ward AB; Wilson IA; Kwong PD Nature; 2011 Nov; 480(7377):336-43. PubMed ID: 22113616 [TBL] [Abstract][Full Text] [Related]
12. Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites. Townsley S; Li Y; Kozyrev Y; Cleveland B; Hu SL J Virol; 2016 Jan; 90(2):829-41. PubMed ID: 26512079 [TBL] [Abstract][Full Text] [Related]
13. Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop. Cale EM; Gorman J; Radakovich NA; Crooks ET; Osawa K; Tong T; Li J; Nagarajan R; Ozorowski G; Ambrozak DR; Asokan M; Bailer RT; Bennici AK; Chen X; Doria-Rose NA; Druz A; Feng Y; Joyce MG; Louder MK; O'Dell S; Oliver C; Pancera M; Connors M; Hope TJ; Kepler TB; Wyatt RT; Ward AB; Georgiev IS; Kwong PD; Mascola JR; Binley JM Immunity; 2017 May; 46(5):777-791.e10. PubMed ID: 28514685 [TBL] [Abstract][Full Text] [Related]
14. Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity. Drummer HE; Hill MK; Maerz AL; Wood S; Ramsland PA; Mak J; Poumbourios P PLoS Pathog; 2013; 9(4):e1003218. PubMed ID: 23592978 [TBL] [Abstract][Full Text] [Related]
15. Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers. Khayat R; Lee JH; Julien JP; Cupo A; Klasse PJ; Sanders RW; Moore JP; Wilson IA; Ward AB J Virol; 2013 Sep; 87(17):9865-72. PubMed ID: 23824817 [TBL] [Abstract][Full Text] [Related]